Biocryst Pharmaceuticals Inc (BCRX)
SBC to Revenue
6.73%
Quarterly · Period ending:
BCRX SBC to Revenue
Latest reported6.73%period ending
Latest reported6.73%period ending
BCRX Quarterly SBC/Revenue (0.00% → 6.73%)
Latest values, visible window
High-resolution chart · PNG
BCRX sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 6.7317% | |
| 10.2466% | |
| 17.8495% | |
| 11.6698% | |
| 13.0417% | |
| 14.6825% | |
| 16.2232% | |
| 14.732% | |
| 12.0486% | |
| 14.7174% | |
| 17.6529% | |
| 14.1558% | |
| 15.5665% | |
| 20.3655% | |
| 19.2118% | |
| 13.1233% | |
| 15.0568% | |
| 19.2316% | |
| 18.0245% | |
| 31.7827% | |
| 15.2765% | |
| 28.7476% | |
| 146.5886% | |
| 47.0829% | |
| 114.2459% | |
| 57.1014% | |
| 9.2838% | |
| 300.2254% | |
| 371.8923% | |
| 56.3445% | |
| 85.1594% | |
| 143.3975% | |
| 16.68% | |
| 73.0131% | |
| 59.4859% | |
| 63.0023% | |
| 75.0565% | |
| 26.0888% | |
| 22.3645% | |
| 25.5958% | |
| 38.5628% | |
| 54.8755% | |
| 41.9817% | |
| 16.738% | |
| 14.221% | |
| 33.0941% | |
| 66.5993% | |
| 43.8851% | |
| 240.0409% | |
| 46.5587% | |
| 8.413% | |
| 40.1005% | |
| 111.9367% | |
| 45.076% | |
| 20.0439% | |
| 20.2569% | |
| 26.9359% | |
| 8.5427% | |
| 17.2282% | |
| 21.7946% | |
| 33.7617% | |
| 26.9917% | |
| 7.8341% | |
| 11.9% | |
| 28.3613% | |
| 5.393% | |
| 2.4517% | |
| 13.1305% | |
| 30.6246% | |
| 30.4657% | |
| 17,116.2116% | |
| 0% | |
| 0% | |
| 22.7805% | |
| 20,201.0791% | |
| 0% | |
| 0% | |
| 0% | |
| 1,261.6065% | |
| 0.3911% | |
| 0.3851% | |
| 0% | |
| 126,477.2128% | |
| 40.625% | |
| 522.4138% | |
| 31.7073% | |
| -154,765.4931% | |
| 0.3704% | |
| 0% | |
| 0% | |
| 14,281.1456% | |
| 0% | |
| 0% | |
| 0% | |
| 33,153.6671% | |
| 0% | |
| 0% | |
| 0% | |
| 3,604.2734% | |
| 0% |